PLTR vs SBUX: Which Is the Better Buy?

Side-by-side comparison of Palantir Technologies Inc. and Starbucks Corporation — fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-06-20.
Palantir Technologies Inc. · Technology
$128.47
-41.4% upside to fair value
Grade C High Quality
VS
Starbucks Corporation · Consumer Cyclical
$100.65
-6.1% upside to fair value
Grade D
QuantHub Verdict
SBUX has more upside to fair value (-6.1%). SBUX trades at a lower forward P/E (76.7x). These are model outputs — not personalized investment advice. See all research →
Valuation & Fundamentals
Metric PLTR SBUX
Current Price $128.47 $100.65
Fair Value Estimate $75.23 $94.50
Upside to Fair Value -41.4% -6.1%
Market Cap $295.0B $114.7B
Forward P/E 133.8x 76.7x
EV / EBITDA 124.7x 25.6x
Price / Sales 56.5x 3.0x
Price / FCF 109.7x 42.1x
Revenue Growth YoY +84.7% +8.8%
Gross Margin 84.1% 20.4%
Operating Margin 38.1% 9.3%
Return on Equity 32.2% -18.3%
Dividend Yield 0% 0%
FCF Yield 0.91% 2.38%
Analyst Consensus Buy Hold
Investment Thesis
PLTR — Palantir Technologies Inc.
Palantir Technologies Inc. is a software infrastructure company specializing in data analytics platforms primarily serving government and commercial clients. The company benefits from a durable competitive moat in government and select commercial verticals, driven by long-tenured founder leadership and high insider ownership. Palantir exhibits very strong recent growth with revenue up approximate…
SBUX — Starbucks Corporation
Starbucks Corporation operates a global coffeehouse chain with a strong brand and a leading digital/mobile platform, serving approximately 90 million customers weekly through over 28,000 stores in 77 countries. The company benefits from a durable competitive moat based on its extensive store footprint, brand recognition, and digital engagement rather than proprietary products. Despite solid reven…
Accumulation Zones
Metric PLTR SBUX
Zone Low $56.42 $70.88
Zone High $63.95 $80.33
In Buy Zone? No No
← PLTR Research    SBUX Research →    All Research